234 related articles for article (PubMed ID: 31740580)
21. Adipose- and muscle-derived Wnts trigger pancreatic β-cell adaptation to systemic insulin resistance.
Kozinski K; Jazurek M; Dobrzyn P; Janikiewicz J; Kolczynska K; Gajda A; Dobrzyn A
Sci Rep; 2016 Aug; 6():31553. PubMed ID: 27527335
[TBL] [Abstract][Full Text] [Related]
22. Novel PORCN inhibitor WHN-88 targets Wnt/β-catenin pathway and prevents the growth of Wnt-driven cancers.
Yang Q; Qin T; An T; Wu H; Xu G; Xiang J; Lei K; Zhang S; Xia J; Su G; Wang D; Xue M; Kong L; Zhang W; Wu S; Li Y
Eur J Pharmacol; 2023 Apr; 945():175628. PubMed ID: 36858339
[TBL] [Abstract][Full Text] [Related]
23. The porcupine inhibitor WNT974 provokes ectodermal lineage differentiation of human embryonic stem cells.
Kalantary-Charvadeh A; Hosseini V; Mehdizadeh A; Nazari Soltan Ahmad S; Rahbarghazi R; Nozad Charoudeh H; Nouri M; Darabi M
Cell Biochem Funct; 2022 Jun; 40(4):359-368. PubMed ID: 35445405
[TBL] [Abstract][Full Text] [Related]
24. Deletion of Porcn in mice leads to multiple developmental defects and models human focal dermal hypoplasia (Goltz syndrome).
Liu W; Shaver TM; Balasa A; Ljungberg MC; Wang X; Wen S; Nguyen H; Van den Veyver IB
PLoS One; 2012; 7(3):e32331. PubMed ID: 22412863
[TBL] [Abstract][Full Text] [Related]
25. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.
Liu J; Pan S; Hsieh MH; Ng N; Sun F; Wang T; Kasibhatla S; Schuller AG; Li AG; Cheng D; Li J; Tompkins C; Pferdekamper A; Steffy A; Cheng J; Kowal C; Phung V; Guo G; Wang Y; Graham MP; Flynn S; Brenner JC; Li C; Villarroel MC; Schultz PG; Wu X; McNamara P; Sellers WR; Petruzzelli L; Boral AL; Seidel HM; McLaughlin ME; Che J; Carey TE; Vanasse G; Harris JL
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20224-9. PubMed ID: 24277854
[TBL] [Abstract][Full Text] [Related]
26. Determination of the membrane topology of PORCN, an O-acyl transferase that modifies Wnt signalling proteins.
Galli LM; Anderson MO; Gabriel Fraley J; Sanchez L; Bueno R; Hernandez DN; Maddox EU; Lingappa VR; Burrus LW
Open Biol; 2021 Jun; 11(6):200400. PubMed ID: 34186010
[TBL] [Abstract][Full Text] [Related]
27. Restoration of WNT4 inhibits cell growth in leukemia-derived cell lines.
García-Castro B; Alvarez-Zavala M; Riveros-Magaña AR; Ortíz-Lazareno PC; Ratkovich-González S; Hernández-Flores G; Bravo-Cuellar A; Jave-Suarez LF; Aguilar-Lemarroy A
BMC Cancer; 2013 Nov; 13():557. PubMed ID: 24274766
[TBL] [Abstract][Full Text] [Related]
28. Modulating Wnt signaling at the root: Porcupine and Wnt acylation.
Torres VI; Godoy JA; Inestrosa NC
Pharmacol Ther; 2019 Jun; 198():34-45. PubMed ID: 30790642
[TBL] [Abstract][Full Text] [Related]
29. Morphological neurite changes induced by porcupine inhibition are rescued by Wnt ligands.
Godoy JA; Espinoza-Caicedo J; Inestrosa NC
Cell Commun Signal; 2021 Aug; 19(1):87. PubMed ID: 34399774
[TBL] [Abstract][Full Text] [Related]
30. The Wnt inhibitor LGK-974 enhances radiosensitivity of HepG2 cells by modulating Nrf2 signaling.
Tian D; Shi Y; Chen D; Liu Q; Fan F
Int J Oncol; 2017 Aug; 51(2):545-554. PubMed ID: 28627706
[TBL] [Abstract][Full Text] [Related]
31. Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist.
Moon J; Zhou H; Zhang LS; Tan W; Liu Y; Zhang S; Morlock LK; Bao X; Palecek SP; Feng JQ; Williams NS; Amatruda JF; Olson EN; Bassel-Duby R; Lum L
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1649-1654. PubMed ID: 28143939
[TBL] [Abstract][Full Text] [Related]
32. WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines.
Sikora MJ; Jacobsen BM; Levine K; Chen J; Davidson NE; Lee AV; Alexander CM; Oesterreich S
Breast Cancer Res; 2016 Sep; 18(1):92. PubMed ID: 27650553
[TBL] [Abstract][Full Text] [Related]
33. Suppression of Wnt/β-Catenin Signaling Is Associated with Downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer's Disease.
Macyczko JR; Wang N; Zhao J; Ren Y; Lu W; Ikezu TC; Zhao N; Liu CC; Bu G; Li Y
Mol Neurobiol; 2023 Jan; 60(1):26-35. PubMed ID: 36215026
[TBL] [Abstract][Full Text] [Related]
34. miR-15a-5p suppresses endometrial cancer cell growth via Wnt/β-catenin signaling pathway by inhibiting WNT3A.
Wang ZM; Wan XH; Sang GY; Zhao JD; Zhu QY; Wang DM
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4810-4818. PubMed ID: 29164582
[TBL] [Abstract][Full Text] [Related]
35. Gastrulation in rabbit blastocysts depends on insulin and insulin-like-growth-factor 1.
Thieme R; Ramin N; Fischer S; Püschel B; Fischer B; Santos AN
Mol Cell Endocrinol; 2012 Jan; 348(1):112-9. PubMed ID: 21827825
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells.
Kleszcz R; Szymańska A; Krajka-Kuźniak V; Baer-Dubowska W; Paluszczak J
Cell Oncol (Dordr); 2019 Aug; 42(4):505-520. PubMed ID: 31089983
[TBL] [Abstract][Full Text] [Related]
37. Deletion of mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of human focal dermal hypoplasia/Goltz syndrome.
Barrott JJ; Cash GM; Smith AP; Barrow JR; Murtaugh LC
Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12752-7. PubMed ID: 21768372
[TBL] [Abstract][Full Text] [Related]
38. WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic Cancers.
Sottnik JL; Shackleford MT; Robinson SK; Villagomez FR; Bahnassy S; Oesterreich S; Hu J; Madak-Erdogan Z; Riggins RB; Corr BR; Cook LS; Treviño LS; Bitler BG; Sikora MJ
Cancer Res Commun; 2024 Jan; 4(1):134-151. PubMed ID: 38112643
[TBL] [Abstract][Full Text] [Related]
39. Porcupine homolog is required for canonical Wnt signaling and gastrulation in mouse embryos.
Biechele S; Cox BJ; Rossant J
Dev Biol; 2011 Jul; 355(2):275-85. PubMed ID: 21554866
[TBL] [Abstract][Full Text] [Related]
40. Discovery and Optimization of a Porcupine Inhibitor.
Duraiswamy AJ; Lee MA; Madan B; Ang SH; Tan ES; Cheong WW; Ke Z; Pendharkar V; Ding LJ; Chew YS; Manoharan V; Sangthongpitag K; Alam J; Poulsen A; Ho SY; Virshup DM; Keller TH
J Med Chem; 2015 Aug; 58(15):5889-99. PubMed ID: 26110200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
